Efthimia M.
- Country
- Greece
- Department
- Hematology Department
Research Overview
Data & Insights
Has run more than one trial at 4 of 24 partner sites.
Specializations
Hematologic Malignancies
This investigator specializes in treating advanced forms of blood cancers, with particular expertise in diffuse large B-cell lymphoma (DLBCL) and acute myeloid leukemia (AML).
- Relapsed/Refractory DLBCL Management
- AML Remission Strategies
- Novel Therapeutic Approaches
The investigator's work encompasses innovative treatment approaches for patients with challenging blood cancer conditions, particularly those who have experienced disease recurrence.
Immunotherapy Applications
The investigator focuses on developing and implementing immunotherapeutic strategies for blood cancers, including the evaluation of targeted immunological treatments such as Galinpepimut-S (GPS).
- Targeted Immune Therapies
- Treatment Resistance Solutions
- Advanced Therapy Development
Their expertise extends to evaluating comparative treatment efficacy and implementing personalized therapeutic approaches for complex hematologic conditions.
Treatment Innovation
The investigator explores novel therapeutic compounds including selinexor (KPT-330) for resistant blood cancers, focusing on improving outcomes for patients with limited treatment options.
- Advanced Treatment Protocols
- Drug Development Assessment
- Therapeutic Optimization
Their work involves evaluating new treatment approaches against established therapies to enhance patient care outcomes in challenging blood cancer cases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.